PROS1 and infection: Nevertheless, our study provides reassuring data about the ability of HM patients to develop a persistent ab response to the S protein, with the exception of RTX-treated subjects, whose ability to generate specific Ab seems almost completely abolished for up to 6 months when this treatment is given within 6 months before infection, whereas patients who had received RTX more remotely apparently retain the ability to mount a humoral response.